Microbial cell surface and gastric mucosal components

Microbial cell surface and gastric mucosal components refers to the collective physical and chemical structures of the stomach lining and the outer membranes of gastrointestinal pathogens. This target is the primary site of action for bismuth-based therapeutic agents used in the treatment of acid-peptic disorders and infections (StatPearls, 2023). These drugs interact with microbial cell walls, particularly those of Helicobacter pylori, to exert bactericidal effects and prevent bacterial colonization (PubMed, 2021). Simultaneously, they bind to host gastric mucus and proteins within ulcerated tissue to create a protective chelate layer that shields the mucosa from corrosive gastric acid and pepsin (NIH, 2022). This dual mechanism promotes the healing of gastric and duodenal ulcers while facilitating the eradication of harmful bacteria. Furthermore, the interaction stimulates local cytoprotective factors such as prostaglandins and bicarbonate, reinforcing the natural gastric mucosal barrier (PubChem, 2024). The target also plays a role in binding enterotoxins, which contributes to the antidiarrheal properties of bismuth compounds (StatPearls, 2023). Overall, it represents a complex pharmacological interface essential for maintaining gastrointestinal integrity and managing microbial overgrowth.

Other names

Microbial cell surfaceGastric mucosal componentsGastric mucus layerBacterial cell wallUlcer base

Bismuth compounds exert bactericidal effects by disrupting microbial cell walls and membranes, inhibiting bacterial enzymes, and preventing adhesion. In the gastric mucosa, they bind to mucus glycoproteins and proteins in the ulcer base to form a protective physical barrier against acid and pepsin, while also stimulating prostaglandin and bicarbonate secretion (StatPearls, 2023; PubMed, 2021).